GreenLight Biosciences Holdings (GRNA) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Medford, MA, United States. El CEO actual es Andrey Juan Zarur.
GRNA tiene fecha de IPO 2022-02-03, 280 empleados a tiempo completo, cotiza en el NASDAQ Global Market, una capitalización de mercado de $45.43M.
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
